CN105596964A - Drug for treating acne - Google Patents
Drug for treating acne Download PDFInfo
- Publication number
- CN105596964A CN105596964A CN201610101239.7A CN201610101239A CN105596964A CN 105596964 A CN105596964 A CN 105596964A CN 201610101239 A CN201610101239 A CN 201610101239A CN 105596964 A CN105596964 A CN 105596964A
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- drug
- treatment
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 42
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 36
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 229940079593 drug Drugs 0.000 title abstract description 8
- 241001106412 Pilea Species 0.000 claims abstract description 11
- 240000002943 Elettaria cardamomum Species 0.000 claims abstract description 10
- 235000005300 cardamomo Nutrition 0.000 claims abstract description 10
- 235000002848 Cyperus flabelliformis Nutrition 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000003390 Chinese drug Substances 0.000 claims description 9
- 241000906682 Hemsleya Species 0.000 claims description 9
- 235000008113 selfheal Nutrition 0.000 claims description 9
- 244000247747 Coptis groenlandica Species 0.000 claims description 8
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 8
- 241001529739 Prunella <angiosperm> Species 0.000 claims description 8
- 235000021530 Streptopus lanceolatus Nutrition 0.000 claims description 8
- 241000756630 Streptopus Species 0.000 claims description 7
- 244000104677 Peltiphyllum peltatum Species 0.000 claims description 6
- 235000014968 Peltiphyllum peltatum Nutrition 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 3
- 238000004806 packaging method and process Methods 0.000 claims 1
- 210000004072 lung Anatomy 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 206010011224 Cough Diseases 0.000 abstract description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 238000010926 purge Methods 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 241001290571 Fuirena Species 0.000 abstract 2
- 241000229150 Neoalsomitra Species 0.000 abstract 2
- 241000857107 Streptopus simplex Species 0.000 abstract 2
- 235000008326 Trichosanthes anguina Nutrition 0.000 abstract 2
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 230000000452 restraining effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000037380 skin damage Effects 0.000 description 11
- 206010033733 Papule Diseases 0.000 description 8
- 230000002757 inflammatory effect Effects 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229960005280 isotretinoin Drugs 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- CKMXBZGNNVIXHC-UHFFFAOYSA-L ammonium magnesium phosphate hexahydrate Chemical compound [NH4+].O.O.O.O.O.O.[Mg+2].[O-]P([O-])([O-])=O CKMXBZGNNVIXHC-UHFFFAOYSA-L 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- -1 chloramphenicolDeng) Chemical compound 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 229940127234 oral contraceptive Drugs 0.000 description 2
- 239000003539 oral contraceptive agent Substances 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 229910052567 struvite Inorganic materials 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- 206010000501 Acne conglobata Diseases 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010036049 Polycystic ovaries Diseases 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 244000144916 Streptopus roseus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 210000003859 smegma Anatomy 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating acne. The drug is prepared from, by weight, 9 parts of herbal carpesii cernui, 10 parts of snake gourd seeds, 1 part of entireleaf neoalsomitra, 4 parts of rhizome coptidis, 9 parts of herb of fanshaped umbrellasedge, 10 parts of spica prunellae, 5 parts of fruits of amomum cardamomum, 7 parts of pilea lomatogramma hand and 8 parts of streptopus simplex. According to the drug, herbal carpesii cernui is used for clearing away heat and toxic materials; snake gourd seeds are used for moistening the lungs and reducing phlegm; entireleaf neoalsomitra is used for restraining oneself and stopping pain; rhizome coptidis is used for purging fire and removing toxins; herb of fanshaped umbrellasedge is used for promoting qi circulation and activating blood circulation; spica prunellae is used for removing stasis and subsiding swelling; the fruits of amomum cardamomum are used for resolving dampness and promoting qi circulation; pilea lomatogramma hand is used for removing toxins and closing sores; streptopus simplex is used for removing heat from the lungs to relieve coughs. All the herbs are used in a combined mode to jointly achieve the effects of promoting blood circulation to remove meridian obstruction and reducing hardness to remove stasis. Clinical experiments prove that the drug can safely and effectively treat acne.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of medicine that is used for the treatment of acne.
Background technology
Acne is the chronic inflammation skin due to a kind of hair follicle that many factors causes, sebaceous glandsSick. The pilosebaceous follicle of the juvenile face of good pastiness and thoracic dorsal. Main pathogenic factor is that sebum too much dividesSecrete, pilosebaceous duct stops up, and bacterium infects, inflammatory reaction etc. Be recognized that at present acnePropionibacterium is a kind of key factor of morbidity. Be divided into papule according to fash form and state of an illness weightType, pustule type, nodular type, cyst type, atrophic type and poly-and type 6 classes.
Clinical manifestation
Acne lesions is apt to occur in face and upper chest and back. The non-inflammation skin of acne damages and shows as openingProperty and closed comedones. It is approximately 1 mm in size that the typical skin of closed comedones (claiming again hoary hair) damagesColour of skin papule, without obvious hair follicle opening. Open comedones (claiming again blackhead) shows as dome-shapedThe significantly hair follicle opening of expansion of papule companion. Acne further develop and can develop into various struvite skinsDamage, show as inflammatory papule, warts, tubercle and tumour. Inflammatory papule takes on a red color, diameter 1~5Millimeter is not etc.; Warts is in the same size, has wherein been full of white fester; Tubercle diameter is greater than 5 millimeters,Having of touching hardened and pain; The position of tumour is darker, has been full of the mixture of fester and blood.These skins damage also can merge and form large inflammatory patch and sinus etc. Struvite skin after damaging and disappearing usuallyLeave over pigmentation, erythema perstans, pitting or hypertrophic scar. Clinically according to acne skinDamage character and the order of severity acne is divided into 3 degree, 4 grades: 1 grade (slightly): only have acne; 2Level (moderate): except acne, also have some inflammatory papules; 3 grades (moderate): except acne,Also have more inflammatory papule or warts; 4 grades (severe): apart from acne, inflammatory papule and wartsGo back nodosity, tumour or scar outward.
The common method of acne treatment
(1) local topical medicine tretinoin (Tretinoin emulsifiable paste, adapalene gel, heZha Luoting gel), benzoyl peroxide, antibiotics (clindamycin, erythromycin, chloramphenicolDeng), azelaic acid, sulphur lotion etc.
(2) the first-selected Tetracyclines of oral antibiotic (minocycline, Doxycycline etc.), secondlyFor macrolides (erythromycin), avoid selecting the antibiotic that is usually used in therapy system infection as a left sideOfloxacin etc. Common 6~12 weeks of antibiotic regimen.
(3) oral isotretinoin is for serious acne, and oral isotretinoin is standard treatment,Also be the effective method of current Acne treatment. The course for the treatment of taking reach minimum intergal dose 60mg/kg asTarget.
(4) antiandrogen is treated as oral contraceptive Compound Cyproterone Acetate Tablets, is applicable to femaleIn property, severe acne patient, with the too high performance of androgen levels (as crinosity, seborrhea etc.)Or Stein-Leventhal syndrome. Delayed acne and female patient that before the menstrual period, acne significantly increases the weight of are alsoCan consider to apply oral contraceptive.
(5) oral glucocorticoid is mainly used in fulminant or acne conglobata, follow short-term,Low dose of, with the principle of additive method use in conjunction.
(6) other,, for the patient that can not tolerate or be reluctant to accept medicine treatment, also can consider thingReason treatment, as PDT (PDT), tartaric acid therapy, laser therapy etc.
Medicinal material involved in the present invention is all recorded in " China's book on Chinese herbal medicine " as seen.
Summary of the invention
The present invention aims to provide a kind of medicine that is used for the treatment of acne, by select suitable medicinal material andIts proportioning, reaches the object of safe and effective healing acne.
In order to achieve the above object, the present invention is by the following technical solutions:
A medicine that is used for the treatment of acne, is characterized in that, it is former by following weight proportionMaterial medicinal material is prepared from: 9 parts of spoon dishes, 10 parts of Chinese Drug Gualouzis, 1 part of henry hemsleya root, 4 parts of the coptiss,9 parts of umbrella plants, 10 parts of selfheals, 5 parts of Amomum cardamomums, 7 parts of Pilea lomatogramma Hand.-Mazzs, 8 parts of twisted-stalks.
Below in conjunction with theories of Chinese materia medica, beneficial effect of the present invention is described:
Inventor thinks, the basic pathogenesis of acne is that lung machine silts up, and stomach accumulated heat is loose. Damp and hotly accumulate for a long time,Cause smegma to cross Sheng, the raw illness of fur. Therefore should focus on eliminating heat from the lung, strong taste in treatment.Reach effect promoting blood circulation and removing obstruction in channels, light hard dissipating bind.
The present invention uses: spoon dish is clearing heat and detoxicating; Chinese Drug Gualouzi moistening lung for removing phlegm; Henry hemsleya root convergencePain relieving; Coptis purging intense heat and detonicating; The umbrella plant promoting flow of qi and blood circulation; Selfheal mass dissipating and swelling eliminating; Amomum cardamomumizationWet promoting the circulation of qi; Pilea lomatogramma Hand.-Mazz removing toxic substances sore; Twisted-stalk removing heat from the lung to relieve cough. All medicines share, play altogether invigorate blood circulation logicalThe merit of network, light hard dissipating bind.
Below in conjunction with clinical trial data declaration beneficial effect of the present invention:
1, physical data
70 routine patients with acne are collected between year May altogether in inventor in May, 2012-2014. Random pointFor: treatment group 40 examples, control group 30 examples. Wherein treatment group man 15 examples, female's 25 examples, the age18~34 years old, the course of disease 1 month~12 years; Control group man 13 examples, female's 17 examples, the age 18~Between 30 years old, the course of disease 1 month~10 years. The data such as two groups of sexes, age, the course of disease are without conspicuousnessDifference, has comparativity.
Western medicine diagnose standard
Distinguish work " clinical dermatology " Western medicine diagnose mark Huaihe River with reference to Zhao. Pubarche morbidity is goodSend out in the flourishing position of the sebaceous glands such as face, upper chest and back, symmetrical. Skin damages as hair follicle moundRash, blackhead, warts, tubercle, tumour and scar, with seborrhea, be chronic process.
1. the people's standard of receiving distinguishes work " clinical dermatology " Western medicine diagnose standard according to Zhao, meets ordinaryThe diagnosis of type acne; 2. meet above-mentioned Syndrome Differentiation of Traditional Chinese Medicine standard person; 3. the age more than 18 years old,Male or female. 4. sign voluntarily Informed Consent Form.
Exclusion standard: 1) gestation or women breast-feeding their children; 2) patient other may affect the treatment observeSkin disease, as psoriasis, lupus erythematosus; 3) Drug that occupational acne or iodine, bromine etc. causeAcne; 4) there are severe cardiac, lung, kidney and disease of hematopoietic system person; 5) treatment the last fortnight is once localOr system is used the medicine of other Acne treatment; 6) do not complete the course for the treatment of or because of serious adverse reaction endOnly curer.
2, methods for the treatment of
The capsule that the oral the present invention for the treatment of group makes according to specific embodiment 3, every day 3 times. Treatment2 months.
The oral Te Weisi of control group (isotretinoin capsules, the accurate word H0055201 of traditional Chinese medicines, the East Sea, ShanghaiEast Sea pharmaceutical factory of Pharmacy stock Co., Ltd) 10mg every day. Treat 2 months.
3, criterion of therapeutical effect and treatment results
3.1 criterion of therapeutical effect
Cure: skin damages and substantially disappears, restrain pain and disappear, skin damages sum minimizing and is more than or equal to 90%;
Effective: skin damages and obviously disappears, the pain of itching obviously alleviates, and skin damages sum minimizing and is more than or equal to 60%But be less than 90%;
Effective: skin damage disappear to some extent, itching pain alleviates, skin damage sum reduce be more than or equal to 20% butBe less than 60%;
Invalid: skin damages and disappears seldom, or skin damages without obviously changing or increasing the weight of, itching pain do not alleviate orAggravation, skin damages sum minimizing and is less than 20%.
3.2 treatment statisticses are in table 1.
Table 1 liang group curative effect comparison
Group | n | Cure | Effective | Effectively | Invalid | Total effective rate (%) | Obvious adverse reaction example |
Treatment group | 40 | 19 | 10 | 8 | 3 | 92.5% | Nothing |
Control group | 30 | 10 | 5 | 3 | 12 | 60% | Allergic 3 examples; |
Visible, the medicine that the present invention makes can safe and effective Acne treatment, and cure rate is high.
Detailed description of the invention
In order to understand better and to implement the present invention, further illustrate this below in conjunction with specific embodimentInvention.
Embodiment 1
Take: 9 grams of spoon dishes, 10 grams of Chinese Drug Gualouzis, 1 gram of henry hemsleya root, 4 grams of the coptiss, umbrella Sha9 grams of grass, 10 grams of selfheals, 5 grams of roud cardamon seeds, 7 grams of Pilea lomatogramma Hand.-Mazzs, 8 grams of twisted-stalks; Add 8Times water gaging, decocts 1.5 hours, filters; Filter residue adds 6 times of water gagings, decocts 1 hour, filters;Merging filtrate, is concentrated into 120 grams, must meet the decoction of one day consumption of normal adult.
Be used for the treatment of acne. Oral, take once every day.
Embodiment 2
Take: 9 grams of spoon dishes, 10 grams of Chinese Drug Gualouzis, 1 gram of henry hemsleya root, 4 grams of the coptiss, umbrella Sha9 grams of grass, 10 grams of selfheals, 5 grams of roud cardamon seeds, 7 grams of Pilea lomatogramma Hand.-Mazzs, 8 grams of twisted-stalks; Add 10Times water gaging, decocts 2 hours, filters; Filter residue adds 8 times of water gagings, decocts 1.5 hours, filters;Merging filtrate, concentrated, dry, pack, must meet the powder of one day consumption of normal adult.
Be used for the treatment of acne. Oral, every bu is taken for twice sooner or later.
Embodiment 3
Take: 9 grams of spoon dishes, 10 grams of Chinese Drug Gualouzis, 1 gram of henry hemsleya root, 4 grams of the coptiss, umbrella Sha9 grams of grass, 10 grams of selfheals, 5 grams of roud cardamon seeds, 7 grams of Pilea lomatogramma Hand.-Mazzs, 8 grams of twisted-stalks; Add 6Times water gaging, decocts 3 times, decocts 1 hour at every turn, merges decoction liquor, concentrated, dry, packs intoCapsule shells, must meet the capsule of one day consumption of normal adult.
Be used for the treatment of acne. Oral, every bu morning, noon and afternoon take for three times.
Claims (4)
1. a medicine that is used for the treatment of acne, is characterized in that, it is by following weight proportionRaw medicinal material is prepared from: 9 parts of spoon dishes, 10 parts of Chinese Drug Gualouzis, 1 part of henry hemsleya root, the coptis4 parts, 9 parts of umbrella plants, 10 parts of selfheals, 5 parts of Amomum cardamomums, 7 parts of Pilea lomatogramma Hand.-Mazzs, abacus78 parts.
2. the medicine that is used for the treatment of acne as claimed in claim 1, is characterized in that, its preparationMethod is: take: 9 parts of spoon dishes, 10 parts of Chinese Drug Gualouzis, 1 part of henry hemsleya root, 4 parts of the coptiss,9 parts of umbrella plants, 10 parts of selfheals, 5 parts of Amomum cardamomums, 7 parts of Pilea lomatogramma Hand.-Mazzs, 8 parts of twisted-stalks;Add 8 times of water gagings, decoct 1.5 hours, filter; Filter residue adds 6 times of water gagings, decocts 1 hour,Filter; Merging filtrate, is concentrated into 120 parts, obtains decoction; Above-mentioned part all refers to weight portion.
3. the medicine that is used for the treatment of acne as claimed in claim 1, is characterized in that, its preparationMethod is: take: 9 parts of spoon dishes, 10 parts of Chinese Drug Gualouzis, 1 part of henry hemsleya root, 4 parts of the coptiss,9 parts of umbrella plants, 10 parts of selfheals, 5 parts of Amomum cardamomums, 7 parts of Pilea lomatogramma Hand.-Mazzs, 8 parts of twisted-stalks;Add 10 times of water gagings, decoct 2 hours, filter; Filter residue adds 8 times of water gagings, decocts 1.5 hours,Filter; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weightPart.
4. the medicine that is used for the treatment of acne as claimed in claim 1, is characterized in that, its preparationMethod is: take: 9 parts of spoon dishes, 10 parts of Chinese Drug Gualouzis, 1 part of henry hemsleya root, 4 parts of the coptiss,9 parts of umbrella plants, 10 parts of selfheals, 5 parts of Amomum cardamomums, 7 parts of Pilea lomatogramma Hand.-Mazzs, 8 parts of twisted-stalks;Add 6 times of water gagings, decoct 3 times, decoct 1 hour at every turn, merge decoction liquor, concentrated, dry,Incapsulate shell, obtain capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610101239.7A CN105596964A (en) | 2016-02-24 | 2016-02-24 | Drug for treating acne |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610101239.7A CN105596964A (en) | 2016-02-24 | 2016-02-24 | Drug for treating acne |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105596964A true CN105596964A (en) | 2016-05-25 |
Family
ID=55977677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610101239.7A Pending CN105596964A (en) | 2016-02-24 | 2016-02-24 | Drug for treating acne |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105596964A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105267482A (en) * | 2014-06-26 | 2016-01-27 | 应丽红 | Formula for treating acne |
-
2016
- 2016-02-24 CN CN201610101239.7A patent/CN105596964A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105267482A (en) * | 2014-06-26 | 2016-01-27 | 应丽红 | Formula for treating acne |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
CN101721594A (en) | Chinese medicinal ointment with antibacterial and antipruritic effects and preparation method thereof | |
CN103432244A (en) | Composition having acne removing function | |
CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
CN114159511A (en) | Traditional Chinese medicine preparation for preventing and treating radioactive skin injury and preparation method thereof | |
CN103845578B (en) | Treatment burn and scald, decubital ulcer, herpes zoster external-use tincture and preparation method | |
CN105030620A (en) | Moisturizing and acne removing facial cleanser and preparing method thereof | |
CN103550424A (en) | Face cleaning product with acne treating effect and preparation method of face cleaning product | |
CN101439114A (en) | Chinese medicine for treating burn and scald, and preparation method thereof | |
CN102727698B (en) | Wound surface nursing powder for treating bedsore | |
CN105596964A (en) | Drug for treating acne | |
CN103610841A (en) | Method for treating stomatitis of bamboo rats | |
CN108721442B (en) | Traditional Chinese medicine composition and preparation for treating burns, scalds and diaper dermatitis and preparation method thereof | |
CN102716381B (en) | Traditional Chinese medicine used for treating appendicitis | |
CN105250568A (en) | Medicinal composition for treating scalds and burns and preparation method thereof | |
CN102018874A (en) | Traditional Chinese medicine preparation for treating swelling | |
CN101036712A (en) | Scald and burn ointment | |
CN104055959A (en) | Traditional Chinese medicine lotion and nursing method for treating gastrointestinal dampness-heat type seborrhoeic dermatitis | |
CN109999111A (en) | A kind of pharmaceutical composition and preparation method thereof for treating acne | |
CN104474405A (en) | Traditional Chinese medicine composition for treating chloasma | |
CN115463182B (en) | Traditional Chinese medicine composition and gel preparation and application thereof in preventing and treating radiodermatitis | |
CN108888660A (en) | A kind of low irritant drug and preparation method thereof for treating acne or acne rosacea | |
CN116036168B (en) | Traditional Chinese medicine composition for treating phlebitis and application thereof | |
CN102920800A (en) | Topical drug composite and application and preparation method thereof | |
CN102727804A (en) | Traditional Chinese medicine composition for treating abscess and boil and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160525 |
|
WD01 | Invention patent application deemed withdrawn after publication |